Related Experiment Video
Updated: Mar 10, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
A case of central diabetes insipidus associated with cardiac dysfunction
Nobumasa Ohara1, Masanori Kaneko2, Tatsuya Suwabe2
1Department of Endocrinology and Metabolism Nagaoka Red Cross Hospital Niigata Japan; Department of Endocrinology and Metabolism Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital Niigata Japan.
Abstract:
Central diabetes insipidus (CDI) results from a deficiency of arginine vasopressin (AVP) secretion. It is treated by replacement therapy with the synthetic AVP analogue desmopressin. To prevent heart failure in patients with CDI accompanied by cardiac dysfunction, controlling sodium and water intake is essential, using the minimum effective dose of desmopressin.
More Related Videos
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Related Concept Videos
Heart Failure Drugs: Diuretics
Cardiomyopathy II: Dilated Cardiomyopathy
Chronic Kidney Disease IV: Nursing Management
Diabetes: Symptoms, Diagnosis, and Complications
Heart Failure II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...